Industry

– Capstan’s foundation is built on research developed by world-renowned mRNA and cell therapy scientists and clinicians at the University of Pennsylvania – Therapy development focused on cell type-specific engineering across oncology, autoimmune disease, blood disorders, and fibrosis – $165 million seed and Series A financings include significant investment from leading biopharmaceutical companies including Pfizer … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Hemophilia Market Analysis by Type (Type A, B, C,), by Treatment (Prophylaxis, On-Demand), by Therapy (Gene, Replacement, Immune Tolerance Induction (ITI) Therapy), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global hemophilia market size is estimated to be USD 12.6 billion in 2021 and is expected … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Saudi Arabia Contract Manufacturing Organizations Market, By Type (Active Pharmaceutical Ingredients (API) Manufacturing, Finished Dosage Formulation (FDF) Development & Manufacturing, Secondary Packaging), By End User, By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. Saudi Arabia contract manufacturing organizations market is expected to witness growth at a steady … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Urinary Catheters Market, By Product (Indwelling Catheters, Intermittent Catheters, External Catheters) By Type (Coated v/s Uncoated) By Usage (Male v/s Female) By Application, By End User, By Company By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. The global urinary catheters market is anticipated to witness an … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “North America Healthcare Staffing Market Forecast to 2028 – COVID-19 Impact and Regional Analysis By Service Type and End Users” report has been added to ResearchAndMarkets.com’s offering. The North America healthcare staffing market is expected to reach US$ 31,101.94 million by 2028 from US$ 20,918.23 million in 2021; it is estimated to grow … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Medical Enzymes Market 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The global medical enzymes market is estimated to progress with a CAGR of 6.78% during the forecast period 2022-2028. Companies Mentioned BASF SE Dupont Roche Holding AG Novozymes Dsm Sanofi Sa Codexis Advanced Enzymes Amano Enzyme Bbi Solutions Thermofisher Scientific Inc … [Read more…]

The €12M Series A round is led by Astanor Ventures; The funds raised will be invested in the next stages of development: bringing the casein production process to industrial scale, perfecting its processed products and initiating the regulatory process; Standing Ovation is participating in the creation of a sustainable agri-food industry by offering alternative proteins … [Read more…]

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces that the first patient has been enrolled in its proof-of-concept clinical trial of SENS-401 (Arazasetron) in patients scheduled for cochlear … [Read more…]

– SparingVision is a French Biotech with the ambition of becoming a leader in genomics in ophthalmology. – Jeito Capital was a major investor in the Series A financing for SparingVision in 2020 and now co-leads the Series B financing to further support the Company’s growth trajectory, in accordance with its investment thesis: accelerating patient’s … [Read more…]

BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc. (NASDAQ: EWTX) today announced the pricing of its upsized underwritten public offering of 11,627,907 shares of its common stock at a price to the public of $10.32 per share. All of the shares are to be sold by Edgewise Therapeutics. In addition, Edgewise Therapeutics has granted the underwriters a 30-day … [Read more…]